Can You Just Take Mounjaro for a Month? (October 2026)

01 · The core answer

Can you take Mounjaro for just a month?

Yes, you can take Mounjaro for just a month, and you are free to stop whenever you choose. The more useful question is whether a month achieves what you hope for. For most people it will not, because the treatment is designed to step up gradually. The starting weeks on 2.5mg are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal.¹

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is used alongside a reduced-calorie diet and increased physical activity. That means a short course is not a shortcut. It is the opening step of a plan that is meant to be reviewed over months.

Weight loss on Mounjaro is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.² If your goal is a noticeable change before an event, a single month is unlikely to deliver it, and it is better to know that before you start than after.

02 · Is this relevant to you?

What a month on 2.5mg realistically gets you

A month on the starting pen gets you through the adjustment phase and tells you how your body responds. You will learn how the weekly injection feels, whether your appetite changes, and which side effects, if any, you notice. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹³

Early loss also includes water weight, so the trend over weeks matters more than any single weigh-in. Three months in, most people are still on the lower rungs of the dose ladder, which is why trial averages at that stage are modest compared with the headline figures. If three months is modest, a single month will be smaller still, and you should set your expectations accordingly.

Slower early progress does not predict failure, because the dose you respond to may still be ahead of you. Stopping at the end of the starting pen means you never find out. That is the main honest argument for speaking to your prescriber about the next dose before you decide.

03 · Your decision

When stopping after a month makes sense

Stopping after a month makes sense if you had side effects you could not tolerate, if your circumstances changed, or if your prescriber advises it after a review. It also makes sense if you decide the treatment is not right for you. None of these is a failure, and none requires you to finish a set number of pens.

What does not make sense is stopping because you feel little at the starting dose. That is expected. A plateau or slow start is not a reason to double doses or add unlicensed products.¹

If you are unsure, the better step is a conversation. Our prescribing team offers monthly reviews, dose-titration and follow-up as part of aftercare, and repeat orders re-check suitability with no auto-shipping, so you are never locked in. If you are comparing options, our guide to a single-month course and our page on doing Mounjaro for a month cover the same question from different angles.

04 · What to do next

What to do next

If you are still deciding whether to start, the sensible route is a free online consultation, reviewed by a GPhC-registered prescriber, with no obligation. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and every later order is £25 off the standard price. You can see current options on the Mounjaro pen page, and the wider picture on our weight loss clinic page. Doses are in stock across the range.

05 · What the first month involves

What the first month of Mounjaro involves

The first month of Mounjaro involves one pen of the 2.5mg starting strength, injected once a week. Mounjaro comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Everyone begins at the lowest strength, and the dose is stepped up after at least four weeks if it is suitable and tolerated.

The purpose of the starting dose is not about weight loss itself. It is to let your body adjust. The 2.5mg starting weeks are about adjustment, and experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal.² That variation is important because it means how you feel in the first weeks says little about how you will feel later.

In practical terms, you will inject on the same day each week, using the pen's own instructions. Needles, a sharps bin and injection guidance are included with every order, so you are not left to work it out alone. Once a pen is in use it can be kept for up to 30 days (not above 30°C) out of the fridge, and unopened pens are stored in the fridge between 2–8°C until first use and keep until the printed expiry date.¹³ If you are unsure about any storage point, check the patient information leaflet or ask the pharmacy.

What you can expect from the first month is mostly information. You will find out how you tolerate the medicine, how your appetite behaves around meals, and whether the weekly routine suits you. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹³ If effects are stronger than that, or do not settle, tell your prescriber rather than waiting.

Early scale movement can mislead in both directions. Early loss includes water weight, so a fast drop may be partly fluid, and a quiet week does not mean nothing is happening. Judge progress by the trend over weeks, not individual weigh-ins. Writing down appetite, portions and side effects each week gives your prescriber something concrete to review.

A good way to think about the month is as a trial of tolerance rather than a test of results. If it goes smoothly, the next step is usually a conversation about moving up a strength. If it does not, that same conversation helps decide whether to pause, adjust or stop. Either way, you leave the month better informed than when you began, which is a perfectly legitimate outcome in its own right.

It is also worth keeping the rest of your routine steady during this time. Eat regular meals, keep fluids up, and avoid making several big changes at once, so that any effect you notice can be linked to the medicine rather than to something else you altered that same week.

06 · How it works and why time matters

How Mounjaro works and why time matters

Mounjaro works by activating two natural gut-hormone receptors at once, which is why it is not a quick-acting product. Tirzepatide is the first treatment of its kind to activate GIP and GLP-1 receptors together. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ Notice what that sentence says: the medicine supports a reduced-calorie diet. It does not replace one. The benefit comes from the combination of appetite support and the food and activity choices you make while it is working.

This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ It also explains why the dose is stepped up. Each higher strength gives your body more to respond to, and the trial results people quote were measured on the higher strengths, not on the starter pen.

Why does time matter? Because a month on the lowest dose gives the medicine only a small window to work with. The headline trial figures come from long treatment periods. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² Those are trial averages, and individual results vary.

Nothing in that result describes what happens on the starting pen alone. It describes treatment on the stated doses over a long period. Using those figures to expect a dramatic change in a month would be a misreading of the trial, and we would rather you hear that from us than be disappointed later.

The mechanism also tells you something about stopping. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ This means that if you stop after a month, the medicine is still in your system for a good while, and appetite effects fade gradually rather than overnight.

The takeaway is that Mounjaro is a medicine you give time to. The dose ladder, the clearance period and the trial design all point the same way. If you want to understand whether to continue, the useful measure is how you respond over months with your prescriber's review, rather than how the first four weeks went.

07 · Results to expect

Weight loss to expect from a short course

The honest expectation from a month on Mounjaro is modest loss, if any that you can measure with confidence. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month.² Several of the questions people ask, such as how much weight you can lose in a month, have no single answer because individual variation is wide.

Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures: in SURMOUNT-1, average weight loss built month by month, with the full 15–21% averages measured at 72 weeks, not 12.²

A sensible three-month expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation. A single month sits well below that. Trials measured results at 72 weeks, so think in months, not days, and judge progress by trend, not individual weigh-ins.

To put the headline figures in context, at 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² These are long-term results on maintenance-range doses, and they should not be read as a promise for a short course.

If you want a worked example, for someone starting at 100 kg, 20.9% is about 21 kg. That is the trial average on 15mg over 72 weeks, not a month's result, and your own result may be different.

Plateaus matter here too. Weight loss on Mounjaro is not linear, and plateaus of a few weeks are normal and expected as the body adapts to a lower weight. If you stop early, you may never reach the part of the journey where the pace becomes clearer. Within the licence, the responses to a plateau are to review food intake honestly because portions drift back up, protect protein and activity, check the basics such as sleep and alcohol, and discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.¹

Prescribers also review response in a structured way. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.² That review point is far beyond a single month, which again shows how short a month is in treatment terms.

08 · What happens when you stop

What happens when you stop Mounjaro

When you stop Mounjaro, the medicine clears slowly and its appetite effects fade over the following weeks. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.¹⁴ Portion sizes, protein, regular meals, activity and sleep are all things you can practise on the starting dose. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² If you stop, those habits are the part you keep.

Before stopping, it is sensible to speak to your prescriber. They can tell you whether stopping suits your situation, whether a break rather than a full stop is appropriate, and what to watch for afterwards. If you have type 2 diabetes or take medicines that affect blood sugar, a conversation matters even more, because other treatments may need reviewing when Mounjaro changes.

If you later decide to restart, do not assume you can pick up at the dose you were last on. Whether a restart should begin at a lower strength is a decision for your prescriber, who will take into account how long it has been and how you tolerated treatment before. Repeat orders with us re-check suitability each time, and there is no auto-shipping, so nothing is sent without your say-so.

If you are on a break because of holiday, illness or a busy period, tell your prescriber rather than adjusting doses yourself. Skipping, doubling or improvising schedules are not approaches we advise. A clear plan agreed with your prescriber is safer than a guess, and it keeps your options open if you want to continue later.

Finally, if you have stopped because of a side effect, you can report it through the Yellow Card scheme as well as telling your prescriber.⁷ Reporting helps the regulator monitor safety and costs you nothing.

09 · Breaks, holidays and short spells

Breaks, holidays and short-term use

Taking Mounjaro short-term or pausing for a holiday is something to plan with your prescriber, not something to improvise. People ask about short courses for several reasons: they want to try it, they have an event, they are worried about long-term use, or they are travelling. Each reason has a slightly different answer, but the common thread is that the medicine is built for gradual use under review.

If you are thinking of trying it for a short spell, the most honest framing is that you are testing tolerance. A short trial can tell you whether you get on with the weekly injection and the side effects. It cannot be expected to deliver the longer-term results seen in trials, which were measured at 72 weeks.² If you have a short-term target such as a wedding, it is better to speak to a prescriber about realistic outcomes than to rely on a month of the starting dose.

For holidays, two questions come up: whether to pause the injection and how to carry the pen. On the first, speak to your prescriber before you go, because the right answer depends on where you are in your dose steps and how long you will be away. We do not advise skipping, stretching or doubling doses to fit around travel.

On the second, storage is the practical point. Unopened pens are kept in the fridge until first use and keep until the printed expiry date. Once a pen is in use it is licensed for up to 30 days (not above 30°C) out of the fridge, and the fridge range is 2–8°C.¹³ For anything else, such as how long an unopened pen can be out of the fridge, check the patient information leaflet or ask the pharmacy rather than guessing. Our next-day delivery arrives in temperature-controlled, discreet packaging, so plan the timing of orders around your travel dates.

If you have travelled and missed a dose, do not double up the next one. Follow the leaflet and call your prescriber if you are unsure what to do. We would always rather you ask than improvise with a prescription medicine.

Some people consider alternating on and off courses. Our related guides on taking Mounjaro for just a short spell and a month-only course go over similar ground if you want a second view.

The bottom line is that a pause or a short spell is allowed, but it should be a decision made with information, not a reaction to a plateau or a bad week.

10 · Safety, interactions and what to avoid

Safety, interactions and what to avoid

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and that review is where your safety questions belong. Even on a short course, you should tell the prescriber about every medicine you take, including anything bought over the counter.

Two interactions are worth knowing. First, Mounjaro can reduce absorption of oral contraceptives because stomach emptying slows, so ask your prescriber what protection you should use.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Second, if you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. That does not mean these medicines cannot be used with Mounjaro, only that your prescriber needs to review them.¹

Tell your prescriber about everything you take, especially warfarin or other narrow-margin medicines, insulin or sulfonylureas.¹³ If you are asking what drugs you should not take with Mounjaro, the safest answer is to share your complete medicine list at consultation and with your pharmacist, rather than relying on a general list.

What should you avoid? Avoid unlicensed products and anyone offering to supply without a consultation or prescription. Counterfeit weight-loss injections are a recognised risk, and the regulator publishes alerts about them.⁷ Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens, and the pharmacy is registered with the GPhC (9012878).

Avoid also adding other things to speed results. A plateau is not a reason to double doses or add unlicensed products. Those practices fall outside the licence and are not something we support.

On everyday habits, treatment works alongside a reduced-calorie diet and increased physical activity. When progress stalls, the licensed responses are practical: review food intake honestly because portions drift back up, protect protein and activity, and check the basics of sleep and alcohol.¹

If you notice new symptoms, discuss them with your prescriber and report side effects through the Yellow Card scheme.¹⁹ If you have severe, persistent stomach pain, pain in the upper right abdomen with fever or yellowing of the skin or eyes, or swelling of the face or throat and difficulty breathing, get medical help straight away rather than waiting for a review.

Finally, remember that benefits are not only about the scales. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial averages and not promises, and they were seen over long treatment periods rather than a single month.

11 · Cost of a short course

What a short course costs

A short course costs one pen at the starting strength, and the price depends on whether it is your first order. The standard price of the 2.5mg pen is £169.99 for four weeks. A new customer's first 2.5mg pen costs £129.99 with code FIRST40, and every later order is £25 off the standard price. Prices were checked 12 October 2026.

If you are thinking about the whole picture, the starting pen is the cheapest part of treatment, because doses rise. The first four pens, covering the 2.5mg, 5mg, 7.5mg and 10mg pens, cost £959.96 at standard prices, before discounts. A first order is £40 less and every later order £25 less. A first year costs £2,711.88 if you settle at 5mg, up to £3,599.88 at 15mg, again at standard prices before discounts.

On payment, we accept Visa and Mastercard, Klarna and pay-monthly options, and there are no subscriptions. The consultation is free and the price shown is the price paid, with no hidden fees. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

On the NHS side, Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. If you are in a NHS pathway, ask your GP what applies to you.

If you decide to go ahead privately, ordering follows three steps: complete the free online consultation, have it reviewed by a GPhC-registered prescriber, then we dispense and dispatch. Same-day dispatch applies when ordered by 3pm, with free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99. See the Mounjaro pen page for current options, and our page on using Mounjaro for a month for a related take.

The standard NHS prescription charge in England is £9.90, but this does not apply to private supply. Whatever route you pick, the key point is the same: agree a plan with a prescriber, then decide how long you want to continue.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹